Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection
Background: Lassa virus (LASV) can cause severe acute systemic infection in humans. No approved antiviral drugs or vaccines are currently available. Antibody-based therapeutics are considered a promising treatment strategy in the management of LASV disease. Methods: We used chimeric Ifnar?/? C57B...
保存先:
主要な著者: | , , , |
---|---|
フォーマット: | 論文 |
言語: | 英語 |
出版事項: |
Philipps-Universität Marburg
2023
|
主題: | |
オンライン・アクセス: | PDFフルテキスト |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
インターネット
PDFフルテキスト請求記号: |
urn:nbn:de:hebis:04-es2024-04459 |
---|---|
出版日付: |
2024-01-18 |
ソース: |
Erstveröffentlichung: Oestereich, L.; Müller-Kräuter, H.; Pallasch, E.; Strecker, T. Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection. Viruses 2023, 15, 1436. https://doi.org/10.3390/v15071436 |
Downloads: |
19 (2024) |
Lizenz: |
https://creativecommons.org/licenses/by/4.0 |
アクセスURL: |
https://archiv.ub.uni-marburg.de/es/2024/0445 https://doi.org/10.3390/v15071436 |